Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

PURPOSE: The research community has focused on defining reliable biomarkers for the early detection of the pathological hallmarks of Alzheimer’s disease (AD). In 2017, the Geneva AD Biomarker Roadmap initiative adapted the framework for the systematic validation of oncological biomarkers to AD, with...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiotis, Konstantinos, Dodich, Alessandra, Boccardi, Marina, Festari, Cristina, Drzezga, Alexander, Hansson, Oskar, Ossenkoppele, Rik, Frisoni, Giovanni, Garibotto, Valentina, Nordberg, Agneta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175292/
https://www.ncbi.nlm.nih.gov/pubmed/33723628
http://dx.doi.org/10.1007/s00259-021-05277-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175292/
https://www.ncbi.nlm.nih.gov/pubmed/33723628
http://dx.doi.org/10.1007/s00259-021-05277-4

Ejemplares similares